AIP
BCAX

Ameritas Investment Partners’s Bicara Therapeutics BCAX Stock Holding History

Ameritas Investment Partners’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.5K Hold
2,893
– – ﹤0.01% 2021
2025
Q4 		$48.7K Sell
2,893
-600
-17% -$10.2K ﹤0.01% 2135
2025
Q3 		$55.2K Hold
3,493
– – ﹤0.01% 2056
2025
Q2 		$32.5K Buy
3,493
+1,474
+73% +$17.6K ﹤0.01% 2448
2025
Q1 		$26.3K Hold
2,019
– – ﹤0.01% 2431
2024
Q4 		$35.2K Buy
+2,019
New +$42K ﹤0.01% 2389

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Ameritas Investment Partners's BCAX Position: Q1 2026 in Review

Ameritas Investment Partners held its Bicara Therapeutics (BCAX) position steady in Q1 2026 at 2,893 shares worth $57.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Ameritas Investment Partners first reported a position in BCAX in Q4 2024 and has held it in 6 quarters since. 146 funds tracked by Wall St. Rank hold BCAX as of Q1 2026.

  • Ameritas Investment Partners held 2,893 shares of Bicara Therapeutics worth $57.5K as of Q1 2026.
  • Ameritas Investment Partners left its Bicara Therapeutics share count unchanged in Q1 2026.
  • Bicara Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2021 holding.
  • Ameritas Investment Partners first reported a position in Bicara Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 146 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.